Stock News

FDA Approves Expansion of Indication for FILSPARI in IgA Nephropathy New Era of Treatment for IgA Nephropathy Patients The FDA has recently approved an expanded indication for FILSPARI, a promising oral medication for patients with IgA nephropathy (IgAN) who are at risk of disease progression. This updated label includes data from the PROTECT Study, showing…

Hypercharge Expands Fleet with 58 New DC Fast Charging Ports for Western Canada’s Energy Infrastructure Provider Vancouver, British Columbia–(Newsfile Corp. – September 5, 2024) – Hypercharge Networks Corp. (TSXV: HC) (OTCQB: HCNWF) (FSE: PB7) Hypercharge Networks Corp., a leading, smart electric vehicle (EV) charging solutions provider and network operator, has announced an additional order of…

Levi & Korsinsky Investigates Cardlytics, Inc. for Securities Law Violations Investigation Commencement New York, NY / ACCESSWIRE / September 5, 2024 / Levi & Korsinsky has started an investigation of Cardlytics, Inc. (“Cardlytics”) (NASDAQ:CDLX) for potential violations of federal securities laws. The investigation comes after Cardlytics released its second quarter 2024 financial results on August…

Investing in Iteris, Inc.: A Cash Opportunity at the Empire State Building The Buzz at the Empire State Building Hey there, fellow investors! Have you heard the latest scoop? Monteverde & Associates PC, also known as the M&A Class Action Firm, is making waves at the Empire State Building in New York City. This top-notch…

Nyxoah to Participate in Upcoming Investor Conferences Moving Forward in Sleep Apnea Treatment Making Strides in Medical Technology Nyxoah SA, a leading medical technology company focusing on innovative solutions for Obstructive Sleep Apnea (OSA), has recently announced its participation in three upcoming investor conferences in New York City. This exciting news comes as the company…

Investors Beware: Class Action Lawsuit Against Sage Therapeutics What’s Happening? The Schall Law Firm, a national shareholder rights litigation firm, has issued a reminder to investors regarding a class action lawsuit against Sage Therapeutics, Inc. The lawsuit alleges violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated by…

Insight Into Broadcom’s Third Quarter Financial Results A Closer Look at the Numbers Broadcom Inc. recently announced impressive financial results for the third quarter of fiscal year 2024. With a revenue of $13,072 million, the company saw a significant increase of 47 percent from the prior year period. Despite a GAAP net loss of $1,875…

Smith & Wesson Brands, Inc. Announces First Quarter Fiscal 2025 Financial Results Financial Highlights: – Q1 Net Sales of $88.3 Million – Q1 Gross Margin of 27.4%; Q1 Non-GAAP Gross Margin of 28.7% – Q1 Net Loss of $0.05/Share; Q1 Adjusted Net Loss of $0.02/Share – Q1 Adjusted EBITDAS Margin of 11.2% – Board of…